97 related articles for article (PubMed ID: 20564180)
21. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of cell polarity in EMT and cancer.
Moreno-Bueno G; Portillo F; Cano A
Oncogene; 2008 Nov; 27(55):6958-69. PubMed ID: 19029937
[TBL] [Abstract][Full Text] [Related]
23. Physician Education: Apoptosis.
Kataoka S; Tsuruo T
Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Panani AD
Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
[TBL] [Abstract][Full Text] [Related]
25. [Cytopathology of the breast--benign and malignant neoplastic conditions].
Moriki T; Takahashi T; Ueda S; Wada M; Ichien M; Hashimoto M
Rinsho Byori; 1999 Jul; 47(7):585-92. PubMed ID: 10442036
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic pathology of the nuclear envelope in human cancers.
Fischer AH
Adv Exp Med Biol; 2014; 773():49-75. PubMed ID: 24563343
[TBL] [Abstract][Full Text] [Related]
27. [Cytopathology--current trends].
Griesser H
Verh Dtsch Ges Pathol; 2001; 85():94-9. PubMed ID: 11894421
[TBL] [Abstract][Full Text] [Related]
28. Cytology of prostatic carcinoma. Quantification and validation of diagnostic criteria.
Böcking A; Auffermann W; Schwarz H; Bammert J; Dörrjer G; Vucicuja S
Anal Quant Cytol; 1984 Jun; 6(2):74-88. PubMed ID: 6465698
[TBL] [Abstract][Full Text] [Related]
29. Radiation-induced genomic instability and its implications for radiation carcinogenesis.
Huang L; Snyder AR; Morgan WF
Oncogene; 2003 Sep; 22(37):5848-54. PubMed ID: 12947391
[TBL] [Abstract][Full Text] [Related]
30. Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions.
Darvishian F; Lin O
Cancer; 2004 Dec; 102(6):355-61. PubMed ID: 15476290
[TBL] [Abstract][Full Text] [Related]
31. Bright and dynamic, constantly updated and enhanced online.?
Hunt T
J Cell Sci; 2000; 113(Pt 24):4377-4378. PubMed ID: 11082030
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic and molecular aspects of lung cancer.
Panani AD; Roussos C
Cancer Lett; 2006 Jul; 239(1):1-9. PubMed ID: 16112428
[TBL] [Abstract][Full Text] [Related]
33. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
Wynter CV
Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
[TBL] [Abstract][Full Text] [Related]
34. The cytoskeleton and cancer.
Hall A
Cancer Metastasis Rev; 2009 Jun; 28(1-2):5-14. PubMed ID: 19153674
[TBL] [Abstract][Full Text] [Related]
35. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
[TBL] [Abstract][Full Text] [Related]
36. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
37. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
Renshaw AA
Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
39. Cell cannibalism and cancer.
Sharma N; Dey P
Diagn Cytopathol; 2011 Mar; 39(3):229-33. PubMed ID: 21319327
[TBL] [Abstract][Full Text] [Related]
40. [Criteria for malignancy and the history of its diagnosis].
PLENGE K
Dtsch Med J; 1951 Dec; 2(23-24):545-9. PubMed ID: 14926450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
